SMYD3 and breast cancer: These data indicate that breast cancer, particularly the basal-like subtype, has a high frequency of CNAs and somatic mutations in several HMTs, including amplification of ASH1L, SETDB1, and SMYD3, as well as homozygous deletion of SETDB2.